ESCRS - PO1021 - Clinical Case Description Of Lens-Laser Correction For Functional Outcome In A Child With Congenital Cataract Using Laser For Residual Myopia In An Eye With Intraocular Lens (Iol) Using Mel-90 And Visumax 500

Clinical Case Description Of Lens-Laser Correction For Functional Outcome In A Child With Congenital Cataract Using Laser For Residual Myopia In An Eye With Intraocular Lens (Iol) Using Mel-90 And Visumax 500

Published 2025 - 43rd Congress of the ESCRS

Reference: PO1021 | Type: Poster | DOI: 10.82333/ez76-dz17

Authors: Monika Izabela Popowska* 1 , Andrey Kachanov 2 , Ludmila Popowska 3

1Department and Clinic of Ophtha Medical University of Warsaw,Department and Clinic of Ophthalmology, Faculty of Medicine, Warsaw,Poland, 2ophtalmology,St.-Petersburg branch of Sv. Fyodorov Eye Microsurgery Clinic North-Western State Medical University , St.-Petersburg,Russian Federation; Department of Ophthalmology,Lumed Clinic,Warszaw,Poland, 3Ophthalmology, Clinic of Ophthalmology,Warszaw,Poland

Purpose

There are two main directions for the correction of residual myopia in eyes with pseudophakia:

- conservative methods of correction,

- surgical methods of correction,

–  INTRAOCULAR methods (with replacement / reimplantation / IOL);

-EXCIMERIC and FEMTOSECOND LASER CORRECTION of residual ametropia after IOL implantation (PRK, LASIK and Femto LASIK, ReLEx® SMILE and others) 

Setting

A 15-years-old girl with high myopia and myopic astigmatism who had IOL implantation in the right eye 

Methods

FemtoLASIK surgery anterior segment of the eye was “calm” and the corneal flap was accurate 

Results

The patient reports a higher maximum uncorrected distance visual acuity just after FemtoLASIK surgery, which exceeds the maximum distance visual acuity with glasses and at the same time the patient reads regular magazine type. 

Conclusions

FemtoLASIK, as the second stage of biooptics in young patients with pseudophakia, allows achieving close to maximum visual acuity with minimal risks and significantly reduces the negative aspects of anisometropia, aniseikonia, intolerance to glasses and soft contact lenses, and eliminates the large surgical risks of invasive IOL reimplantation technology.